secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2022-12-23T23:59:59+00:00
Accession:  0001493152-22-036486
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus Therapeutics enters $20M equity purchase agreement with Lincoln Park Capital
--------------------------------------------------------------------------------

- Lincoln Park committed to buy up to $20M of Indaptus common stock over 36 months (extendable to 48).
- Company controls timing of sales; Lincoln Park cannot require purchases or engage in short selling.
- Indaptus issued 142,450 initial commitment shares; up to 76,220 additional shares may follow after $10M sold.
- Net proceeds will be used for working capital and general corporate purposes.
- Agreement includes standard representations, indemnification, and automatic termination on bankruptcy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315222036486/0001493152-22-036486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315222036486/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer